At the end of summer we told you all about a new initiative of the National Brain Tumor Society called the Clinical Trial Endpoints Initiative, which aims to jumpstart brain tumor treatment development. At the time we were just getting back from an extremely fruitful meeting with the U.S. Food & Drug Administration (FDA), which […]
The Society for Neuro-Oncology (SNO), the preeminent trade organization for those working in the brain tumor research arena, seeks to advance the field through research and education. SNO hosts an annual multi-day meeting that is ‘must-go’ for brain cancer researchers, clinicians, surgeons, patient advocacy organizations, and biopharma industry executives
Dr. David Louis, Pathologist-in-Chief at Massachusetts General Hospital (MGH) and Benjamin Castleman Professor of Pathology at Harvard Medical School, is an internationally recognized expert in brain tumor pathology and molecular genetics.